Clinical Trials View

Title Condition Hospital Physician Trial Status
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy Stage IB Breast Cancer, Stage II Breast Cancer Saint Anne's Hospital, Saint Anne's Hospital Norman Wolmark, MD Recruiting
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Saint Anne's Hospital, Saint Anne's Hospital Mack Roach Recruiting
A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma Bladder Urothelial Carcinoma, Distal Urethral Carcinoma, Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter, Proximal Urethral Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Urethra Carcinoma, Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter, Regional Urothelial Carcinoma of the Renal Pelvis and Ureter, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Stage IV Urethral Cancer, Ureter Carcinoma Norwood Hospital Jonathan Rosenberg Active, not recruiting
Comprehensive Prospective Study for Mode of Dialysis Therapy and Outcomes in ESRD End-Stage Renal Disease Holy Family Hospital Yong-Lim Kim, M.D., Ph.D. Recruiting
Exercise Programs for Stroke: Effect of an Inpatient Supplementary Practice Program on Lower Extremity Function Cerebrovascular Accident (Stroke) Holy Family Hospital Janice Eng, William Miller, Andrew Dawson, Penny Brasher Completed
Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment With Lenalidomide (Revlimid®) Alone and in Combination With Epoetin Alfa (Procrit®) in Subjects With Low- or Intermediate-1 Risk MDS and Symptomatic Anemia Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Holy Family Hospital Alan List Recruiting
A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 (Aflibercept; NSC-724770) in Patients With Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC) Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Holy Family Hospital Jeffrey Allen Completed
A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative, HER2/Neu Positive, Male Breast Carcinoma, Progesterone Receptor Negative, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v6, Stage IV Breast Cancer Holy Family Hospital Hope Rugo Active, not recruiting
Efficacy and Safety of Augmentation of Creatine for the Patients With Major Depressive Disorder Major Depressive Disorder Holy Family Hospital Perry F Renshaw, MD, PhD, In Kyoon Lyoo, MD, PhD, MMS Completed
A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of TC-5214 in the Treatment of MDD With Subjects Who Are Partial Responders or Non-Responders to Citalopram Therapy Major Depressive Disorder, Depression Holy Family Hospital Alfredo N Rivera, MD Completed